Literature DB >> 1299078

A model protocol for a diabetes and other noncommunicable disease field survey.

G K Dowse1, P Zimmet.   

Abstract

Field surveys of diabetes and other noncommunicable diseases and their risk factors are increasingly being performed in both developed and developing countries. Although individual priorities and circumstances will influence survey design, a model survey manual and protocol is described which might assist investigators in formulating plans and preparing manuals for their own surveys. The model presented has been successfully used in developing countries, for both rural and urban communities, over more than a decade. It describes examples of survey objectives, and gives specific details of survey procedures and measurement techniques which may be utilized. It contains sufficient flexibility to allow its adaptation to local circumstances.

Entities:  

Mesh:

Year:  1992        PMID: 1299078

Source DB:  PubMed          Journal:  World Health Stat Q        ISSN: 0379-8070


  9 in total

1.  Differentials and Determinants of Syndrome 'X' and its Role as Coronary Risk among Healthy Middle Aged Indian Army Personnel.

Authors:  Rajvir Bhalwar; V C Ohri; B L Somani; A S Kasthuri
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Sitting less and moving more for improved metabolic and brain health in type 2 diabetes: 'OPTIMISE your health' trial protocol.

Authors:  Christian J Brakenridge; Paul A Gardiner; Ruth V Grigg; Elisabeth A H Winkler; Brianna S Fjeldsoe; Mia A Schaumberg; Neville Owen; Elizabeth G Eakin; Stuart J H Biddle; Marjory Moodie; Robin M Daly; Daniel J Green; Neale Cohen; Len Gray; Tracy Comans; Matthew P Buman; Ana D Goode; Phuong Nguyen; Lan Gao; Genevieve N Healy; David W Dunstan
Journal:  BMC Public Health       Date:  2022-05-10       Impact factor: 4.135

Review 3.  Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Davood Khalili; Fereidoun Azizi; Samaneh Asgari; Azita Zadeh-Vakili; Amir Abbas Momenan; Arash Ghanbarian; Fatemeh Eskandari; Farhad Sheikholeslami; Farzad Hadaegh
Journal:  Int J Endocrinol Metab       Date:  2018-10-13

4.  Contrasting compositions of sitting, standing, stepping, and sleeping time: associations with glycaemic outcome by diabetes risk.

Authors:  Christian J Brakenridge; Genevieve N Healy; Parneet Sethi; Alison Carver; John Bellettiere; Agus Salim; Sebastien F M Chastin; Neville Owen; David W Dunstan
Journal:  Int J Behav Nutr Phys Act       Date:  2021-12-04       Impact factor: 6.457

5.  Sex Differences in Cumulative Exposure to Metabolic Risk Factors Before Hypertension Onset: The Cohort of the Tehran Lipid and Glucose Study.

Authors:  Azra Ramezankhani; Fereidoun Azizi; Amir Abbas Momenan; Farzad Hadaegh
Journal:  J Am Heart Assoc       Date:  2021-11-15       Impact factor: 6.106

6.  Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults.

Authors:  Ilhan Satman; Beyhan Omer; Yildiz Tutuncu; Sibel Kalaca; Selda Gedik; Nevin Dinccag; Kubilay Karsidag; Sema Genc; Aysegul Telci; Bulent Canbaz; Fulya Turker; Temel Yilmaz; Bekir Cakir; Jaakko Tuomilehto
Journal:  Eur J Epidemiol       Date:  2013-02-14       Impact factor: 8.082

7.  Assessment of the magnitude of contextual and individual demographic effects on diabetes mellitus and glucose intolerance in rural Southwest China: a multilevel analysis.

Authors:  Ke-wei Wang; Zhan-kun Shu; Le Cai; Jun-Qing Wu; Wei Wei
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

8.  Obesity in Botswana: time for new cut-off points for abdominal girth?

Authors:  Churchill Lukwiya Onen
Journal:  Cardiovasc J Afr       Date:  2016-07-04       Impact factor: 1.167

9.  Predisposing factors of long-term responsiveness in a cardio-metabolic cohort: Tehran Lipid and Glucose Study.

Authors:  Leila Cheraghi; Parisa Amiri; Golnaz Vahedi-Notash; Sara Jalali-Farahani; Davood Khalili; Fereidoun Azizi
Journal:  BMC Med Res Methodol       Date:  2021-08-09       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.